194 related articles for article (PubMed ID: 10510889)
1. Ratio of gamma-seminoprotein to prostate-specific antigen for the detection of prostate cancer: its discrimination power could be influenced by the assay methods of PSA and/or gamma-seminoprotein.
Akino H; Suzuki Y; Oyama N; Kanamaru H; Okada K
Int J Urol; 1999 Sep; 6(9):440-5. PubMed ID: 10510889
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of prostate specific antigen and gamma-seminoprotein ratio for diagnosing prostate cancer].
Akino H; Suzuki Y; Okada K
Nihon Rinsho; 1998 Aug; 56(8):2003-5. PubMed ID: 9750496
[TBL] [Abstract][Full Text] [Related]
3. The value of gamma-seminoprotein in combination with prostate specific antigen in detecting prostate cancer.
Nakashima J; Nagata H; Sumitomo M; Miyajima A; Tachibana M; Baba S; Jitsukawa S; Murai M
Int J Urol; 1999 Jun; 6(6):298-304. PubMed ID: 10404306
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Dec; 34(12):2143-8. PubMed ID: 2467543
[TBL] [Abstract][Full Text] [Related]
5. Measurement of prostate specific antigen and gamma-seminoprotein ratio: a new means of distinguishing benign prostatic hyperplasia and prostate cancer.
Demura T; Watarai Y; Togashi M; Hirano T; Ohashi N; Koyanagi T
J Urol; 1993 Nov; 150(5 Pt 2):1740-5. PubMed ID: 7692111
[TBL] [Abstract][Full Text] [Related]
6. Significance of free prostate-specific antigen and gamma-seminoprotein in the screening of prostate cancer.
Higashihara E; Nutahara K; Kojima M; Okegawa T; Miura I; Miyata A; Kato M; Sugisaki H; Tomaru T
Prostate Suppl; 1996; 7():40-7. PubMed ID: 8950363
[TBL] [Abstract][Full Text] [Related]
7. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
[TBL] [Abstract][Full Text] [Related]
8. Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
Steuber T; Nurmikko P; Haese A; Pettersson K; Graefen M; Hammerer P; Huland H; Lilja H
J Urol; 2002 Nov; 168(5):1917-22. PubMed ID: 12394676
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of tandem PSA for the diagnosis and follow-up of prostate cancer].
Okaneya T; Mizusawa H; Taguchi I; Yoneyama T
Hinyokika Kiyo; 1996 Nov; 42(11):861-7. PubMed ID: 8973936
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of serum prostate-specific antigen-alpha1-antichymotrypsin complex values in diagnosis of prostate cancer: a cooperative study.
Kuriyama M; Ueno K; Uno H; Kawada Y; Akimoto S; Noda M; Nasu Y; Tsushima T; Ohmori H; Sakai H; Saito Y; Meguro N; Usami M; Kotake T; Suzuki Y; Arai Y; Shimazaki J
Int J Urol; 1998 Jan; 5(1):48-54. PubMed ID: 9535601
[TBL] [Abstract][Full Text] [Related]
11. [Prostate specific antigen (PSA)/gamma-seminoprotein ratio in the cases with PSA levels less than or equal to 10.0 ng/ml].
Demura T; Ohyama I; Togashi M; Ohashi N; Chikaraishi T; Hirano T; Koyanagi T
Nihon Hinyokika Gakkai Zasshi; 1995 Feb; 86(2):296-303. PubMed ID: 7534845
[TBL] [Abstract][Full Text] [Related]
12. Diurnal rhythm of serum gamma-seminoprotein in patients with untreated prostate cancer: comparison of the original and revised assay kits.
Akimoto S; Akakura K; Ohki T; Shimazaki J
Int J Urol; 1994 Sep; 1(3):263-7. PubMed ID: 7542157
[TBL] [Abstract][Full Text] [Related]
13. [Studies of prostate-specific antigen (PSA) immunoassays--differences in characteristic of immunoreactivity and reference materials among the kits].
Umeda H; Sumi S; Honda M; Hosoya Y; Arai K; Yano M; Koga F; Nakajima K; Nakanishi K; Maeda S; Kitahara S; Yoshida K
Nihon Hinyokika Gakkai Zasshi; 1998 Mar; 89(3):426-33. PubMed ID: 9577558
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the clinical value of complexed PSA and total PSA in the discrimination between benign prostatic hyperplasia and prostate cancer.
Froehner M; Hakenberg OW; Koch R; Schmidt U; Meye A; Wirth MP
Urol Int; 2006; 76(1):27-30. PubMed ID: 16401917
[TBL] [Abstract][Full Text] [Related]
15. [The incidence of the variability of the free PSA/total PSA ratio on the early diagnosis of prostate cancer].
de La Taille A; Houlgatte A; Houdelette P; Berlizot P; Fournier R; Ricordel I
Prog Urol; 1997 Jun; 7(3):455-63. PubMed ID: 9273075
[TBL] [Abstract][Full Text] [Related]
16. [Discrepancy between the serum levels of gamma seminoprotein and prostate-specific antigen in patients with prostatic neoplasms. Both true or either untrue].
Fujino A; Mukai N; Kawakami T; Yokoyama E; Mashimo S; Endo T; Ishibashi A; Koshiba K; Aoki Y; Itoh H
Nihon Hinyokika Gakkai Zasshi; 1991 Apr; 82(4):541-50. PubMed ID: 1711133
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein].
Yoshiki T; Okada K; Oishi K; Yoshida O
Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559
[TBL] [Abstract][Full Text] [Related]
18. Value of the free to total prostate specific antigen ratio and prostate specific antigen density for detecting prostate cancer in Japanese patients.
Maeda H; Arai Y; Okubo K; Aoki Y; Okada T; Maekawa S
Int J Urol; 1998 Jul; 5(4):343-8. PubMed ID: 9712442
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of prostate specific antigen/gamma-seminoprotein ratio for diagnosis of prostate cancer].
Demura T; Watarai Y; Togashi M; Oohashi N; Chikaraishi T; Hirano T
Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1046-53. PubMed ID: 7688442
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of hyper sensitive PSA assay kits for determination on low range of prostate specific antigen in prostate cancer].
Akimoto S; Akakura K; Ohki T; Shimazaki J; Kuriyama M; Kawada Y
Nihon Hinyokika Gakkai Zasshi; 1995 Feb; 86(2):256-62. PubMed ID: 7534843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
